{"disease":{"id":"cutaneous-adverse","name":"cutaneous adverse"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05046054","title":"The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Propofol Injection","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Kyungpook National University Hospital","has_results":false},{"nct_id":"NCT06647342","title":"The Effect of Reduced Bleomycin in Electrochemotherapy Treatment","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":55,"lead_sponsor_name":"Julie Gehl","has_results":false},{"nct_id":"NCT06682845","title":"Association Between Drug-related Cutaneous Adverse Events and Progression Free Survival in Patients Treated with Enfortumab Vedotin","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07110662","title":"New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}